Commonwealth Bank of Australia’s Pediatrix Medical MD Stock Holding History

Commonwealth Bank of Australia’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-20,700	Closed	-$522K	–	573
2019 Q2	$522K	Buy	20,700 +8,100	+64%	+$218K	0.01%	723
2019 Q1	$342K	Hold	12,600	–	–	﹤0.01%	738
2018 Q4	$415K	Buy	12,600 +1,200	+11%	+$48.2K	﹤0.01%	640
2018 Q3	$531K	Buy	+11,400	New	+$523K	0.01%	650
2017 Q4	–	Sell	-1,065	Closed	-$45K	–	862
2017 Q3	$45K	Sell	1,065 -1,140	-52%	-$54.2K	﹤0.01%	666
2017 Q2	$132K	Buy	2,205 +293	+15%	+$17.4K	﹤0.01%	665
2017 Q1	$132K	Buy	1,912 +812	+74%	+$56.4K	﹤0.01%	645
2016 Q4	$73K	Buy	1,100 +300	+38%	+$19.5K	﹤0.01%	701
2016 Q3	$53K	Buy	800 +300	+60%	+$20.5K	﹤0.01%	745
2016 Q2	$36K	Buy	500 +300	+150%	+$20.6K	﹤0.01%	764
2016 Q1	$13K	Buy	+200	New	+$13.3K	﹤0.01%	812
2013 Q3	–	Sell	-11,700	Closed	-$536K	–	1247
2013 Q2	$536K	Buy	+11,700	New	+$524K	﹤0.01%	918

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Commonwealth Bank of Australia's MD Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Pediatrix Medical (MD) in Q3 2019, closing a stake of 20,700 shares — an estimated $522K sold.

Commonwealth Bank of Australia first reported a position in MD in Q2 2013 and held it in 12 quarters. The position peaked at $536K in Q2 2013. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

Commonwealth Bank of Australia reported no remaining Pediatrix Medical position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 20,700 Pediatrix Medical shares in Q3 2019, an estimated $522K.
Commonwealth Bank of Australia first reported a position in Pediatrix Medical in Q2 2013 and held it in 12 quarters.
Commonwealth Bank of Australia's Pediatrix Medical position peaked at $536K in Q2 2013.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.